IPP Bureau
Avion Pharmaceuticals announces USFDA approval of DHIVY
By IPP Bureau - February 15, 2022
Parkinson's disease treatment is the first and only carbidopa/levodopa (CD/LD) tablet designed to be divided for precise dosing
Lynparza plus abiraterone effective in standard-of-care in 1st-line metastatic castration-resistant prostate cancer
By IPP Bureau - February 15, 2022
These results will be presented on 17 February at the 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Launches and margin sustainability hold key for Glenmark: ICICI Direct
By IPP Bureau - February 15, 2022
Key takeaways of Q3FY22 quarter & conference call highlights
UFlex introduces a range of innovative and sustainable packaging solutions
By IPP Bureau - February 15, 2022
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
India’s tech-enabled vaccination drive applauded at India-Africa Health Summit
By IPP Bureau - February 15, 2022
It will open new frontier for south-to-south collaboration and innovation transfer
PyraMed telemedicine offers ‘Second Opinion Services’ for rural patients
By IPP Bureau - February 15, 2022
The service has already been initiated in Maharashtra but being net-based it is easily available for patients all across the country
Crysta IVF onboards Dr. Neeta Jain as Head, Clinic Operations
By IPP Bureau - February 15, 2022
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Visionflex chooses Vonage for its next-gen remote healthcare and diagnostic services
By IPP Bureau - February 14, 2022
Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices
Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
By IPP Bureau - February 14, 2022
Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data
WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19
By IPP Bureau - February 14, 2022
The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification
Zydus gets 180 days of shared exclusivity for Roflumilast tablets
By IPP Bureau - February 14, 2022
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
Clinical trials demonstrated safety of AstraZeneca and Sputnik Light vaccines combination
By IPP Bureau - February 14, 2022
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
Kriya Medical Technologies receives manufacturing license for KRIVIDA Novus RT-PCR Kit
By IPP Bureau - February 14, 2022
The KRIVIDA Novus RT-PCR kit can detect the Omicron variant, its sub-lineages, and the Delta variant in 45 minutes
Glenmark to commercialize AstraZeneca’s asthma drug in Columbia
By IPP Bureau - February 14, 2022
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct
By IPP Bureau - February 14, 2022
Key takeaways of recent quarter & conference call highlights
